DCM
Diag Capital Management Portfolio holdings
AUM
$87.4M
This Quarter Return
-15.25%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$87.4M
AUM Growth
–
Cap. Flow
+$87.4M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
50.17%
Holding
40
New
40
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Baxter International
BAX
|
$5.66M |
| 2 |
ATNX
Athenex, Inc. Common Stock
ATNX
|
$5.45M |
| 3 |
Zimmer Biomet
ZBH
|
$4.95M |
| 4 |
AbbVie
ABBV
|
$4.65M |
| 5 |
Incyte
INCY
|
$4.59M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 90.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
LivaNova
LIVN
$3.17B
| $1.1M | 1.25% |
+11,974
| New | +$1.1M |
|
|
MTEM
27
DELISTED
Molecular Templates, Inc.
MTEM
| $985K | 1.13% |
+16,256
| New | +$985K |
|
|
FOMX
28
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $960K | 1.1% |
+146,432
| New | +$960K |
|
29
Verrica Pharmaceuticals
VRCA
$48.3M
| $937K | 1.07% |
+11,495
| New | +$937K |
|
30
Neurocrine Biosciences
NBIX
$14.3B
| $876K | 1% |
+12,266
| New | +$876K |
|
31
Dentsply Sirona
XRAY
$2.92B
| $757K | 0.87% |
+20,347
| New | +$757K |
|
|
AXNX
32
DELISTED
Axonics, Inc. Common Stock
AXNX
| $702K | 0.8% |
+46,485
| New | +$702K |
|
|
ARYAU
33
DELISTED
ARYA Sciences Acquisiton Corp. Unit
ARYAU
| $522K | 0.6% |
+50,500
| New | +$522K |
|
34
ADMA Biologics
ADMA
$4.03B
| $435K | 0.5% |
+182,100
| New | +$435K |
|
35
Madrigal Pharmaceuticals
MDGL
$9.65B
| $326K | 0.37% |
+2,890
| New | +$326K |
|
36
Arvinas
ARVN
$575M
| $311K | 0.36% |
+24,210
| New | +$311K |
|
|
NEOS
37
DELISTED
Neos Therapeutics, Inc
NEOS
| $278K | 0.32% |
+168,642
| New | +$278K |
|
38
AnaptysBio
ANAB
$613M
| $95K | 0.11% |
+1,493
| New | +$95K |
|